About Lung Cancer Treatment
Lung cancer treatment is planned jointly by a thoracic surgeon, a medical oncologist, a radiation oncologist and a pulmonologist. The plan depends heavily on the cell type and on how far the disease has spread, so staging comes before any treatment decision.
This guide explains what the hospital assesses and what to ask its team. It is background reading, not medical advice.
Cell type changes everything
Lung cancer is broadly divided into non-small cell lung cancer, which accounts for the large majority of cases, and small cell lung cancer, which behaves differently and is usually treated with chemotherapy and radiation rather than surgery.
Within non-small cell disease, molecular testing of the biopsy sample looks for specific mutations. Where one is found, a targeted oral drug may be used instead of, or alongside, conventional chemotherapy. PD-L1 testing guides whether immunotherapy is appropriate. These tests take time, and a plan given before they return is provisional.
What the hospital needs before it can plan
Expect to be asked for the biopsy and histopathology report, molecular and PD-L1 testing where already done, a recent CT chest and a PET-CT if available, pulmonary function tests, and reports of any treatment given elsewhere. Imaging should be supplied on disc.
Treatment approaches
Surgery
Where the disease is confined and lung function allows, part or all of a lung may be removed. Lobectomy removes one lobe; segmentectomy or wedge resection removes less. Several partner hospitals offer video-assisted thoracoscopic surgery, which uses small incisions rather than opening the chest, where the tumour position allows it.
Radiation therapy
Used alone, alongside chemotherapy, or after surgery. Stereotactic body radiation therapy delivers a high dose to a small, well-defined tumour over a few sessions and is sometimes offered when surgery is not suitable.
Drug therapy
Chemotherapy, targeted therapy and immunotherapy are used in different combinations depending on cell type, stage and molecular findings. These typically run in cycles over months.
Planning a stay around cycles
Drug therapy for lung cancer is rarely a single admission. Ask the hospital which cycles must be given in India, whether later cycles can be transferred to an oncologist at home, and what monitoring is needed between them. Settle this before booking travel.
Questions worth asking the treating hospital
What is the cell type and stage, and what does that mean for the plan? Has molecular and PD-L1 testing been done, and did it change the recommendation? Is surgery an option, and what does my lung function say about that? How long in total, and how much can be done at home?
Ask the hospital for its own case volumes and outcomes. Outcomes depend on your stage, your general health and the treating team.
How Massvaa Care helps
We share your reports with the oncology teams at partner hospitals, return their written plan and itemised estimate on hospital letterhead, and coordinate the visa invitation, arrival and accommodation. We do not give medical opinions and we do not take a share of your treatment cost. You pay the hospital directly.
Any range quoted before the tumour board has reviewed your case is indicative only. Cancer costs vary widely with stage, subtype and the number of cycles, so the hospital's written estimate is the figure to rely on.
